Neurodegeneration is the common denominator of hundreds of different disorders, collectively called “neurodegenerative diseases.” Scientific and public attention has focused on just a few of these, most notably Alzheimer’s disease (AD). Many others have essentially been neglected, including a group of rare diseases collectively known as prion diseases.
Prati, F., Bolognesi, M.L. (2015). Tackling neurodegeneration with multi-target and theranostic small molecules. Washington, : ACS Division of Medicinal Chemistry.
Tackling neurodegeneration with multi-target and theranostic small molecules
PRATI, FEDERICA;BOLOGNESI, MARIA LAURA
2015
Abstract
Neurodegeneration is the common denominator of hundreds of different disorders, collectively called “neurodegenerative diseases.” Scientific and public attention has focused on just a few of these, most notably Alzheimer’s disease (AD). Many others have essentially been neglected, including a group of rare diseases collectively known as prion diseases.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
